The move came two days after a court upheld the Federal Trade Commission’s challenge to the deal on antitrust grounds.
Read More Genetic Engineering, Tests (Medical), Antitrust Laws and Competition Issues, Decisions and Verdicts, Mergers, Acquisitions and Divestitures, Regulation and Deregulation of Industry, European Union, Federal Trade Commission, Grail Inc, Illumina Inc
